Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Lobe Sciences Ltd (LOBE) operate in?
Lobe Sciences Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Lobe Sciences Ltd (LOBE) current stock price?
As of the latest data, Lobe Sciences Ltd stock price is CA$0.07, with a previous close of CA$0.09. Lobe Sciences Ltd lost -CA$0.02 in the last trading session, representing a -17.65% loss.
What is Lobe Sciences Ltd (LOBE) current market capitalization?
Lobe Sciences Ltd market cap is approximately 21.57 million.
What is Lobe Sciences Ltd (LOBE) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.04.
Does Lobe Sciences Ltd (LOBE) pay dividends?
No. Lobe Sciences Ltd does not pay a dividend.
When is Lobe Sciences Ltd (LOBE) next earnings report?
Lobe Sciences Ltd is expected to release its next earnings report on November 30, 2026.
What is Lobe Sciences Ltd (LOBE) beta (volatility) score?
Lobe Sciences Ltd has a beta of -0.064, indicating lower volatility than the overall market.